Lilly wraps up $8bn acquisition of Loxo Oncology
US pharma giant Eli Lilly and Company (Lilly) has wrapped up its previously announced $8 billion acquisition of Connecticut-based biopharma
Continue readingCoverage of Global Pharma Industry News
US pharma giant Eli Lilly and Company (Lilly) has wrapped up its previously announced $8 billion acquisition of Connecticut-based biopharma
Continue readingUS biopharma company Bristol-Myers Squibb (BMS) has entered into a clinical collaboration with Compugen to evaluate the combination of its
Continue readingIrish biopharma company Alkermes said that it has expanded an ongoing phase 1 trial for its immuno oncology drug ALKS
Continue readingIsraeli pharma company Compugen has dosed the first patient in the phase 1 clinical trial which is evaluating the company’s
Continue readingXencor has launched a phase 1 clinical trial of its bispecific antibody XmAb20717, which is being developed for the treatment
Continue reading